Hanzhi Luo
Overview
Explore the profile of Hanzhi Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao V, Yang R, Das A, Luo R, Luo H, McNally D, et al.
Nat Commun
. 2025 Jan;
16(1):684.
PMID: 39814735
No abstract available.
2.
Gao V, Yang R, Das A, Luo R, Luo H, McNally D, et al.
Nat Commun
. 2024 Nov;
15(1):9432.
PMID: 39487131
Identifying cell-type-specific 3D chromatin interactions between regulatory elements can help decipher gene regulation and interpret disease-associated non-coding variants. However, achieving this resolution with current 3D genomics technologies is often infeasible...
3.
Luo H, Kharas M
Cancer Res
. 2024 Jun;
84(17):2759-2760.
PMID: 38924716
Dysregulated biomolecular condensates, formed through multivalent interactions among proteins and nucleic acids, have been recently identified to drive tumorigenesis. In acute myeloid leukemia (AML), condensates driven by RNA-binding proteins alter...
4.
Feng W, Ladewig E, Salsabeel N, Zhao H, Lee Y, Gopalan A, et al.
bioRxiv
. 2024 Apr;
PMID: 38585869
To gain insight into how ERG translocations cause prostate cancer, we performed single cell transcriptional profiling of an autochthonous mouse model at an early stage of disease initiation. Despite broad...
5.
Luo H, Cortes-Lopez M, Tam C, Xiao M, Wakiro I, Chu K, et al.
Cell Stem Cell
. 2023 Dec;
30(12):1658-1673.e10.
PMID: 38065069
Stem cells regulate their self-renewal and differentiation fate outcomes through both symmetric and asymmetric divisions. mA RNA methylation controls symmetric commitment and inflammation of hematopoietic stem cells (HSCs) through unknown...
6.
Dao T, Xiong G, Mun S, Meyerberg J, Korontsvit T, Xiang J, et al.
Blood
. 2023 Dec;
143(6):507-521.
PMID: 38048594
Chimeric antigen receptor T-cell (CAR T) therapy has produced remarkable clinical responses in B-cell neoplasms. However, many challenges limit this class of agents for the treatment of other cancer types,...
7.
Gao V, Yang R, Das A, Luo R, Luo H, McNally D, et al.
bioRxiv
. 2023 Aug;
PMID: 37546906
The identification of cell-type-specific 3D chromatin interactions between regulatory elements can help to decipher gene regulation and to interpret the function of disease-associated non-coding variants. However, current chromosome conformation capture...
8.
Herrejon Chavez F, Luo H, Cifani P, Pine A, Chu E, Joshi S, et al.
Nat Commun
. 2023 Apr;
14(1):2290.
PMID: 37085479
Tissue homeostasis is maintained after stress by engaging and activating the hematopoietic stem and progenitor compartments in the blood. Hematopoietic stem cells (HSCs) are essential for long-term repopulation after secondary...
9.
Kotini A, Carcamo S, Cruz-Rodriguez N, Olszewska M, Wang T, Demircioglu D, et al.
Blood Cancer Discov
. 2023 Apr;
4(4):318-335.
PMID: 37067914
Significance: We report the generation of patient-derived iPSC models of all major genetic groups of human AML. These exhibit phenotypic hallmarks of AML in vitro and in vivo, inform the...
10.
Klatt M, Dao T, Yang Z, Liu J, Mun S, Dacek M, et al.
Blood
. 2022 Apr;
140(8):861-874.
PMID: 35427421
Target identification for chimeric antigen receptor (CAR) T-cell therapies remains challenging due to the limited repertoire of tumor-specific surface proteins. Intracellular proteins presented in the context of cell surface HLA...